COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,287 Articles (22,759 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 1017: Articles 10161-10170  | Next

Heterologous vaccination with inactivated and mRNA vaccines increases B and T cell responses to SARS-CoV-2
Zuo, F., Abolhassani, H., Du, L., Piralla, A., Bertoglio, F., de Campos-Mata, L., Wan, H., Schubert, M., Wang, Y., Sun, R., Cassaniti, I., Vlachiotis, S., Kumagai-Braesch, M., Andrell, J., Zhang, Z., Xue, Y., Wenzel, E. V., Calzolai, L., Varani, L., Rezaei, N., Chavoshzadeh, Z., Baldanti, F., Hust, M., Hammarstrom, L., Marcotte, H., Pan-Hammarstrom, Q.
10.1101/2022.01.04.22268755 — Posted: 2022-01-05
Differential Effects of Race/Ethnicity and Social Vulnerability on COVID-19 Positivity, Hospitalization, and Death in the San Francisco Bay Area
Cho, W. K. T., Hwang, D. G.
10.1101/2022.01.04.22268760 — Posted: 2022-01-05
Containment of a multi-index B.1.1.7 outbreak on a university campus through a genomically-informed public health response
Martin, E. T., Lauring, A. S., Montgomery, J. P., Valesano, A. L., Eisenberg, M. C., Sheen, D., Nord, J., Ernst, R. D., Mortenson, L. Y., Valdez, R., Niknafs, Y., Conway, D., Rifat, S. F., Bagdasarian, N., Lyon-Callo, S., Collins, J., Blakenship, H., Soehnlen, M., Marquez, J.
10.1101/2022.01.04.22268758 — Posted: 2022-01-05
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals
Naranbhai, V., Nathan, A., Kaseke, C., Berrios, C., Khatri, A., Choi, S., Getz, M. A., Tano-Menka, R. K. K., Ofoman, O., Gayton, A. C., Senjobe, F., St. Denis, K., Lam, E. C., Garcia-Beltran, W. F., Balazs, A. B., Walker, B. D., Iafrate, A. J., Gaiha, G. D.
10.1101/2022.01.04.21268586 — Posted: 2022-01-05
Detection of fecal coliforms and SARS-CoV-2 RNA in sewage and recreational waters in the Ecuadorian Coast: a call for improving water quality regulation
Cardenas, M., Patinoa, L., Pernia, B., Erazo, R., Munoz, C., Valencia-Avellan, M., Lozada, M., Regato-Arrata, M., Barrera, M., Aquino, S., Moyanoc, S., Fuentes, S., Duque, J., Velazquez-Araque, L., Carpio, B., Mendez-Roman, C., Calle, C., Cardenas, G., Guizado-Herrera, D., Lucia Tello, C., Bravo-Basantes, V., Zambranod, J., Francis, J. D., Uyaguari, M.
10.1101/2022.01.04.22268771 — Posted: 2022-01-05
Effects of Varying Approaches to Lifting COVID-19 Pandemic Restrictions in the United States
Galarraga, J. E., Popovsky, D., Delijani, K., Hanson, H., Hanlon, M.
10.1101/2022.01.04.22268766 — Posted: 2022-01-05
The epidemiological impact of the Canadian COVID Alert App
Sun, S., Shaw, M., Moodie, E. E., Ruths, D.
10.1101/2022.01.04.21268588 — Posted: 2022-01-05
Factors Associated with COVID-19 Testing among People who Inject Drugs: Missed Opportunities for Reaching those Most at Risk
Yeager, S., Abramovitz, D., Harvey-Vera, A. Y., Vera, C. F., Algarin, A. B., Smith, L. R., Rangel, G., Artamonova, I., Patterson, T. L., Bazzi, A. R., Brugman, E. L., Strathdee, S. A.
10.1101/2022.01.04.22268749 — Posted: 2022-01-05
Validation of a novel fluorescent lateral flow assay for rapid qualitative and quantitative assessment of total anti-SARS-CoV-2 S-RBD binding antibody units (BAU) from plasma or fingerstick whole-blood of COVID-19 vaccinees
Younes, N., Al-Sadeq, D. W., Shurrab, F., Zedan, H., Abou Saleh, H., Abo Halawa, B., Al Hamaydeh, F., Elsharafi, A., Daas, H., Thomas, S., Aboalmaaly, S., Al Farsi, A., Al-Buainain, R., Ataelmannan, S., Paul, J., Saadi, A., YASSINE, H. M., Majdalawieh, A. F., Ismail, A., Abu-Raddad, L. J., Nasrallah, G.
10.1101/2022.01.04.22268754 — Posted: 2022-01-05
Autophagy and evasion of immune system by SARS-CoV-2. Structural features of the Non-structural protein 6 from Wild Type and Omicron viral strains interacting with a model lipid bilayer.
Bignon, E., Marazzi, M., Grandemange, S., Monari, A.
10.1101/2022.01.05.475107 — Posted: 2022-01-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).